
AMGN
Amgen Inc.
$286.00
+$0.59(+0.21%)
71
Overall
80
Value
63
Tech
--
Quality
Market Cap
$153.65B
Volume
3.05M
52W Range
$253.30 - $339.17
Target Price
$315.07
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $21.7B | $23.0B | $44.6B | $47.5B | $24.5B | $25.4B | $26.0B | $26.3B | $28.2B | $33.4B | ||
Total Revenue | $21.7B | $23.0B | $22.8B | $23.7B | $23.4B | $25.4B | $26.0B | $26.3B | $28.2B | $33.4B | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $4.2B | $4.2B | $4.1B | $4.1B | $4.4B | $6.2B | $6.5B | $6.4B | $8.5B | $12.9B | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $17.4B | $18.8B | $18.8B | $19.6B | $19.0B | $19.3B | $19.5B | $19.9B | $19.7B | $20.6B | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $9.0B | $9.0B | $8.8B | $9.4B | $9.3B | $10.1B | $11.9B | $10.4B | $11.8B | $13.3B | ||
Research & Development | $4.1B | $3.8B | $3.6B | $3.7B | $4.1B | $4.2B | $6.3B | $4.4B | $4.8B | $6.0B | ||
Research Expense | $4.1B | $3.8B | $3.6B | $3.7B | $4.1B | $4.2B | $4.8B | $4.4B | $4.8B | $6.0B | ||
Selling, General & Administrative | $4.9B | $5.2B | $5.2B | $5.6B | $5.2B | $5.9B | $5.6B | $5.9B | $7.1B | $7.3B | ||
Selling & Marketing Expenses | -- | $489.0M | $620.0M | $674.0M | $789.0M | $962.0M | $843.0M | $841.0M | $647.0M | $987.0M | ||
General & Administrative Expenses | $4.9B | $5.2B | $5.2B | $5.6B | $5.2B | $5.9B | $5.6B | $5.9B | $7.1B | $7.3B | ||
Promotion & Advertising | -- | $489.0M | $620.0M | $674.0M | $789.0M | $962.0M | $843.0M | -- | -- | -- | ||
Salaries & Wages | $-120.0M | $-112.0M | $-118.0M | $-67.0M | $-67.0M | $-72.0M | $-74.0M | -- | -- | -- | ||
Depreciation & Amortization | $727.0M | $619.0M | $604.0M | $630.0M | $635.0M | $640.0M | $644.0M | $661.0M | $824.0M | $805.0M | ||
Depreciation & Amortization | $727.0M | $619.0M | $604.0M | $630.0M | $635.0M | $640.0M | $644.0M | -- | -- | -- | ||
Amortization | $14.8B | $14.8B | $14.8B | $14.7B | $19.4B | $16.6B | $15.2B | $16.1B | $32.6B | $27.7B | ||
Other Operating Expenses | $-413.0M | $-425.0M | $-447.0M | $-173.0M | $-215.0M | $-165.0M | $-171.0M | -- | -- | -- | ||
OPERATING INCOME | ||||||||||||
Operating income | $8.5B | $9.8B | $10.0B | $10.3B | $9.7B | $9.1B | $7.6B | $9.6B | $7.9B | $7.3B | ||
EBITDA | $11.2B | $12.5B | $12.9B | $12.9B | $12.6B | $13.0B | $11.3B | $12.2B | $14.8B | $13.4B | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | $1.1B | $1.3B | $1.3B | $1.4B | $1.3B | $1.3B | $1.2B | $1.4B | $2.9B | $3.2B | ||
Intinc | -- | -- | -- | -- | -- | -- | -- | -- | $1.2B | $510.0M | ||
Net Non-Operating Interest Income/Expense | $-1.1B | $-1.3B | $-1.3B | $-1.4B | $-1.3B | $-1.3B | $-1.2B | $-1.4B | $-2.9B | $-3.2B | ||
Gain on Sale of Securities | $132.0M | $306.0M | $147.0M | $29.0M | $92.0M | $37.0M | -- | -- | -- | -- | ||
Other Income/Expense | $-603.0M | $-629.0M | $-928.0M | $-674.0M | $-753.0M | $-256.0M | $-259.0M | $-814.0M | $-2.8B | $-506.0M | ||
Other Special Charges | $603.0M | $629.0M | $928.0M | $674.0M | $753.0M | $256.0M | $259.0M | $-814.0M | $2.8B | $506.0M | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | $132.0M | $19.0M | $88.0M | $12.0M | -- | -- | -- | -- | -- | -- | ||
Special Income Charges | $-21.0M | $-19.0M | $-88.0M | $-12.0M | -- | -- | -- | -- | $-267.0M | -- | ||
Impairment of Capital Assets | $-111.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $9.1B | $10.4B | $10.9B | $10.9B | $10.4B | $9.4B | $7.9B | $8.8B | $10.7B | $7.8B | ||
Pre-Tax Income | $8.0B | $9.2B | $9.6B | $9.5B | $9.1B | $8.1B | $6.7B | $7.3B | $7.9B | $4.6B | ||
INCOME TAX | ||||||||||||
Tax Provision | $1.0B | $1.4B | $7.6B | $1.2B | $1.3B | $869.0M | $808.0M | $794.0M | $1.1B | $519.0M | ||
NET INCOME | ||||||||||||
Net Income | $6.9B | $7.7B | $2.0B | $8.4B | $7.8B | $7.3B | $5.9B | $6.6B | $6.7B | $4.1B | ||
Net Income (Continuing Operations) | $6.9B | $7.7B | $2.0B | $8.4B | $7.8B | $7.3B | $5.9B | $6.6B | $6.7B | $4.1B | ||
Net Income (Discontinued Operations) | $6.9B | $7.7B | $2.0B | $8.4B | $7.8B | $7.3B | $5.9B | $6.6B | $6.7B | $4.1B | ||
Net Income (Common Stockholders) | $6.9B | $7.7B | $23.8B | $32.1B | $9.0B | $7.3B | $5.9B | $6.6B | $6.7B | $4.1B | ||
Normalized Income | $5.2B | $6.0B | $6.3B | $7.5B | $7.2B | $6.4B | -- | -- | -- | -- | ||
TOTALS | ||||||||||||
Total Expenses | $13.2B | $13.2B | $12.9B | $13.5B | $13.7B | $16.3B | $18.3B | $16.8B | $20.3B | $26.2B | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $758.0M | $748.0M | $731.0M | $661.0M | $605.0M | $586.0M | $570.0M | $538.0M | $535.0M | $537.0M | ||
Average Shares Outstanding (Diluted) | $766.0M | $754.0M | $735.0M | $665.0M | $609.0M | $590.0M | $573.0M | $541.0M | $538.0M | $541.0M | ||
Shares Outstanding | $752.1M | $736.5M | $720.6M | $622.3M | $589.8M | $577.6M | $538.4M | $534.0M | $535.9M | $537.2M | ||
Basic EPS | $9.15 | $10.32 | $2.71 | $12.7 | $12.96 | $12.4 | $10.34 | $12.18 | $12.56 | $7.62 | ||
Basic EPS (Continuing Operations) | $9.15 | $10.32 | $2.71 | $12.7 | $12.96 | $12.4 | $10.34 | $12.18 | $12.56 | $7.62 | ||
Diluted EPS | $9.06 | $10.24 | $2.69 | $12.62 | $12.88 | $12.31 | $10.28 | $12.11 | $12.49 | $7.56 | ||
Diluted EPS (Continuing Operations) | $9.06 | $10.24 | $2.69 | $12.62 | $12.88 | $12.31 | $10.28 | $12.11 | $12.49 | $7.56 | ||
Dividend Per Share | -- | -- | -- | $5.41 | $5.95 | $6.56 | $7.22 | $7.76 | $8.52 | $9.13 | ||
OTHER METRICS | ||||||||||||
Development Expense | -- | -- | -- | -- | -- | -- | $1.5B | -- | -- | -- | ||
Earnings from equity interest | -- | -- | -- | -- | -- | -- | $-33.0M | -- | $-11.0M | $10.0M | ||
Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | -- | -- | $-33.0M | -- | $-11.0M | $10.0M | ||
Other Gand A | $4.9B | $5.2B | $5.2B | $5.6B | $5.2B | $5.9B | $5.6B | $5.9B | $7.1B | $7.3B | ||
Rent And Landing Fees | -- | -- | -- | $166.0M | -- | -- | -- | -- | -- | -- | ||
Restruct | $132.0M | $19.0M | $88.0M | $12.0M | -- | -- | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | AMGN | $286.00 | +0.2% | 3.05M |
3 | ||||
4 | ||||
5 | ||||
6 |